Skip to main content
. 2023 Jul 6;17:2025–2033. doi: 10.2147/DDDT.S408304

Table 3.

Treatment-Related Adverse Events of Any Grade and Grade 3/4 AEs in All Patients

Adverse Events Any Grade n=246 (%) Grade 3/4 n=246 (%)
General Asthenia 8 (3.2) 0
Hypoproteinemia 1 (0.4) 1 (0.4)
Gastrointestinal system Elevated hepatic enzymes& 3 (1.2) 0
Nausea, vomit or diarrhea 21 (8.5) 0
Renal system Proteinuria 7 (2.8) 0
Musculoskeletal system Pain and arthralgia# 45 (18.3) 5 (2.0)
Hematologic system Leukopenia 14 (5.7) 8 (3.2)
Thrombocytopelemia 4 (1.6) 0
Cardiovascular system Hypertension 24 (9.8) 4 (1.6)
Bradycardia 1 (0.4) 1 (0.4)
Atrial fibrillation 1 (0.4) 1 (0.4)
Dermatologic system Ulcer* 7 (2.8) 2 (0.8)
PPE/ rash 5 (2.0) 0
Others Fistula 1 (0.4) 0
Hemorrhage 10 (4.0) 3 (1.2)
Thrombosis 2 (0.8) 3 (1.2)

Notes: *Including oral and virginal ulcers. #Mainly hand and foot pain and arthralgia. &Elevated hepatic enzymes included aspartate aminotransferase increased, alanine transaminase increased, and γ-glutamyl transpeptidase increased.

Abbreviation: PPE, palmoplantar erythrodysesthesia.